Crossmark

Transfer of the longevity-associated variant of BPIFB4 gene rejuvenates immune system and vasculature by a reduction of CD38+ macrophages and NAD+ decline

Crossref DOI link: https://doi.org/10.1038/s41419-022-04535-z

Published Online: 2022-01-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ciaglia, Elena https://orcid.org/0000-0002-8035-4583
Lopardo, Valentina

Montella, Francesco

Carrizzo, Albino

Di Pietro, Paola

Malavolta, Marco https://orcid.org/0000-0002-8442-1763
Giacconi, Robertina https://orcid.org/0000-0002-1468-2140
Orlando, Fiorenza

Cattaneo, Monica

Madeddu, Paolo

Vecchione, Carmine

Puca, Annibale Alessandro https://orcid.org/0000-0002-0347-1460
Funding

Funding for this research was provided by:

Fondazione Cariplo (n.2016-0874)

italian ministry of health "Ricerca Corrente"
License Information

Text and Data Mining valid from 2022-01-27

Version of Record valid from 2022-01-27
More Information

Article History

Received: 6 August 2021

Revised: 20 December 2021

Accepted: 13 January 2022

First Online: 27 January 2022

Competing interests

: AAP and CV own shares of LGV1 Inc. and have filed a patent. AAP and EC are co-inventors of one international patent application. The remaining authors declare no competing interests.

Document is current

Any future updates will be listed below